对于他类药物的药理动力学和药物载体作用的个体间变异性
Takeshi Hirota1, Ichiro Ieiri1
1Department of Pharmacy, Kyushu University Hospital, Fukuoka, Japan.
Expert opinion on drug metabolism & toxicology
|January 22, 2024
概括
了解他类药物相互作用和个体变异性是预防副作用的关键. 肠道细菌,疾病和遗传学等因素显著影响他类药物的作用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物新陈代谢 药物新陈代谢
- 临床药房 临床药房
背景情况:
- 类药物是用于降低胆固醇的HMG-CoA减少酶抑制剂.
- 肌肉毒性是一种与他类药物的剂量和机制相关的潜在副作用.
- 对于他类药物的药理动力学的变化,需要了解影响因素.
研究的目的:
- 审查肝脏和肠道的他类药物代谢.
- 讨论影响他类药物的药理动力学的药物相互作用.
- 探索影响他类药理动学的个体间变量.
主要方法:
- 相关文章的文献评论.
- 在2023年5月进行的PubMed搜索.
- 关于他类药物的代谢和可变性信息的综合.
主要成果:
- 药物相互作用显著改变了他的药理动力学.
- 肠道微生物群,疾病状态和遗传多形态都会导致变异性.
- 斯坦丁的代谢发生在肝脏和肠道中.
结论:
- 药物相互作用强烈影响他的药理动力学.
- 肠道微生物群,疾病和遗传学是个人间变异的重要贡献者.
- 优化他类药物治疗需要考虑疾病进展和同时服用的药物.
相关概念视频
Nonlinear Pharmacokinetics: Role of Transporters
51
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
51
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
40
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
40
Hepatic Drug Clearance: Role of Transporters
60
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
60
Factors Affecting Drug Biotransformation: Biological
153
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
153
Nonlinear Pharmacokinetics: Causes of Nonlinearity
191
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
191
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
148
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
148


